Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Nivolumab is a monoclonal antibody targeting the PD-1 receptor, produced via recombinant DNA technology in CHO cells. Its molecular formula is C6895H10651N1827O2142S66 with CAS No. 946414-33-5.
Application
- Oncology Manufacturing: Supply for clinical trials and commercial formulation of anti-cancer therapies.
- Research & Development: Reagent for immuno-oncology mechanism studies and biomarker validation.
- Distribution: Bulk supply to pharmaceutical contract manufacturers and global logistics networks.
Precautions
Strictly store at 2°C to 8°C; avoid freezing or direct light. Use only under professional medical supervision due to potential immune-related adverse events and biosafety risks during handling.